In this video, Motley Fool health-care analyst David Williamson discusses what investors can expect from Celgene's (CELG) upcoming earnings report and what to look for going forward.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Foolish Preview: Celgene Earnings
By Dave Williamson
–
Jan 23, 2013 at 5:52PM
NASDAQ: CELG
Celgene
What investors can expect from Celgene's earnings report.
David Williamson has no position in any stocks mentioned, and neither does The Motley Fool. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.